| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
0.0002 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0005 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0005 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |